Recommended Global Pharmaceutical Sciences Webinars & Conferences
Europe & UK
Asia Pacific & Middle East
Canada
Euro Pharmacology 2025
About Conference
Pharmaceutical Conferences cordially invites participants from all over the world to attend “21st Annual Congress on Pharmacology and Toxicology”, scheduled during November 20-21, 2025 Paris, France The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster Sessions. Pharmacology & Toxicology is a global platform to discuss and learn about research Advances in Pharmacology, Neuropharmacology & Psychopharmacology, Toxicology, Nursing Pharmacology, Ethnopharmacology, Food & Chemical Toxicology.
Why to attend?
Join your lords around the world focused on knowledge about Pharmacology and related developments, which is your solitary best chance to reach the largest accumulation of members from the Pharmacology communal, conduct protests, distribute information, meet with current and potential professionals, make a squish with a new research works, and receive name acknowledgement at this 2-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Pharmacology are characteristics of this conference.
Target Audience
• Researchers
• Directors, CEO’s of Organizations
• Scholars from Pharmacology, Pharmaceutical, Toxicology backgrounds
• PhD Scholars
• Drug Delivery Technology Manufacturers
• Business Development Managers
• Distributors and Suppliers of Drug Delivery Technologies
• Students, Professors, Researchers, and Faculty of Pharmacology & Pharmaceutical Sciences from Universities and Medical Colleges
• Researchers from Pharmaceutical Companies, Pharmacy & Pharmacology Associations and Societies
• Health professionals
• Pharmacists, Pharmacologists, & Toxicologists
• Business development professionals, Consultants, Pharma, and Toxicology Testing service providers
• Quality control specialists
• Graduates and post graduates in industrial pharmacy
• Medical Devices Manufacturing Companies, CRO
• Data Management Companies.
• Pharmaceutical legislators and regulators
• Toxicology Testing Companies & Organizations
Sessions and Tracks
Clinical Pharmacology and Therapeutics explores the science behind drug development, optimization, and personalized medicine. It focuses on pharmacokinetics, pharmacodynamics, drug interactions, and precision medicine to enhance therapeutic outcomes. This field integrates clinical trials, biomarkers, and translational medicine to support safe and effective pharmaceutical use. With advancements in biologics, gene therapy, and digital therapeutics, it is essential in improving individualized care, minimizing adverse drug reactions, and advancing global healthcare. Our conference will spotlight the latest research, regulatory updates, and innovations in this rapidly evolving discipline.
Track-2: Molecular and Cellular Pharmacology
Molecular and Cellular Pharmacology delves into the intricate mechanisms of drug action at the molecular level, emphasizing cellular interactions, signaling pathways, and pharmacokinetics. This field plays a pivotal role in elucidating the effects of therapeutic agents on cellular functions, highlighting drug absorption, distribution, metabolism, and excretion. By understanding these processes, researchers can optimize drug efficacy and minimize toxicity, paving the way for personalized medicine. Key areas of focus include receptor-ligand interactions, enzyme modulation, and gene expression regulation, all contributing to the advancement of novel therapeutic strategies and drug development for complex diseases.
Pharmacokinetics and pharmacodynamics play pivotal roles in drug development, influencing therapeutic efficacy and safety profiles. Pharmacokinetics focuses on drug absorption, distribution, metabolism, and excretion, guiding dosing regimens and optimizing treatment outcomes. Pharmacodynamics, on the other hand, explores drug-receptor interactions, elucidating the mechanisms behind therapeutic effects and side effects. Together, these disciplines enable the design of precision medicine strategies, ensuring drugs are administered effectively to achieve desired clinical outcomes while minimizing adverse reactions. Understanding their intricate relationship enhances drug efficacy, streamlines clinical trials, and supports personalized therapeutic approaches in diverse patient populations.
Drug Discovery, Design, and Development encompass a multi-disciplinary approach integrating cutting-edge technologies, bioinformatics, and molecular modeling to identify novel therapeutic agents. This process spans target identification, hit-to-lead optimization, preclinical testing, and clinical trials. Advances in computational drug design, high-throughput screening, and biomarker discovery are revolutionizing the field, enabling precision medicine and accelerating time-to-market for new treatments. By leveraging systems biology, cheminformatics, and AI-driven methodologies, researchers are uncovering innovative strategies to combat complex diseases, including cancer, neurodegenerative disorders, and metabolic diseases. This conference will foster collaboration, driving forward the future of drug innovation and therapeutic development.
Toxicology: Mechanisms and Risk Assessment explores the intricate biochemical and molecular pathways of toxicity, emphasizing cellular interactions and organ system vulnerabilities. This session delves into contemporary methodologies for hazard identification, dose-response evaluation, and exposure assessment. By integrating cutting-edge risk analysis frameworks, attendees will gain insights into predictive toxicology models, ensuring robust risk management strategies in regulatory settings. Experts will highlight advancements in high-throughput screening, biomarker identification, and computational toxicology, offering a comprehensive understanding of environmental and pharmaceutical toxicants. This session equips professionals with essential tools to navigate the complexities of risk assessment and enhance public health protection.
Explore cutting-edge advancements in Systems Pharmacology and Drug Modeling at our upcoming conference. This event delves into innovative approaches, integrating computational and experimental techniques to optimize drug development processes. Key topics include predictive modeling, pharmacokinetics, bioinformatics, and personalized medicine. Leading experts will share insights on the latest methodologies shaping drug efficacy, safety, and precision therapies. Attendees will gain valuable knowledge on leveraging system biology and data-driven models to enhance therapeutic outcomes. Join us for an enriching experience that bridges pharmacology, biotechnology, and computational sciences, fostering collaboration and innovation in drug discovery
Pharmacogenomics integrates genetic data with pharmacology, enabling tailored therapeutic strategies. By understanding individual genetic variations, personalized medicine enhances drug efficacy and minimizes adverse reactions. This approach transforms treatment paradigms, particularly in chronic diseases and oncology, offering precision therapies that are customized for each patient. The convergence of genomics, bioinformatics, and clinical pharmacology accelerates the development of novel, individualized treatment protocols, optimizing healthcare outcomes
Immunopharmacology plays a pivotal role in advancing vaccine development by exploring the interaction between drugs and immune responses. Through targeted modulation of immune pathways, innovative therapies are emerging to enhance vaccine efficacy and safety. Cutting-edge research focuses on optimizing adjuvants, exploring novel antigen delivery systems, and developing personalized vaccines to address global health challenges. Collaboration between immunologists, pharmacologists, and clinicians is essential for translating these scientific discoveries into transformative clinical applications. This symposium will highlight recent breakthroughs and provide a platform for discussing future directions in vaccine development, ensuring better preparedness for emerging infectious diseases.
Neuropharmacology and CNS Drug Research explore the intricate interactions between pharmacological agents and the central nervous system. This field focuses on advancing therapeutic strategies for neurodegenerative diseases, psychiatric disorders, and pain management. With a multidisciplinary approach, research aims to optimize drug efficacy, minimize side effects, and unravel molecular mechanisms underpinning neurological conditions. The development of novel compounds and personalized medicine holds significant promise for transforming clinical outcomes. Attendees will engage in discussions about cutting-edge drug discovery, neurobiological pathways, and the future of CNS therapeutics, fostering collaboration among scientists, clinicians, and industry leaders to address global healthcare challenges.
Track-10: Industrial and Regulatory Toxicology
Industrial and Regulatory Toxicology focuses on the assessment and management of chemical, biological, and physical hazards in industrial settings. This field involves evaluating exposure risks, regulatory compliance, and the safety of products and processes. It plays a crucial role in ensuring public health through rigorous testing, data analysis, and policy development. Experts in toxicology, risk assessment, and environmental health collaborate to mitigate potential harms. This conference will delve into innovative research, emerging regulations, and best practices to advance safety protocols in industries. Attendees will gain invaluable insights into the future of toxicology and its regulatory landscape.
The Cancer Pharmacology and Chemotherapeutics session explores advanced therapeutic strategies for cancer treatment, emphasizing the molecular mechanisms behind drug action, resistance, and efficacy. Experts will discuss novel pharmacological agents, targeted therapies, and personalized medicine approaches that enhance treatment outcomes. Attendees will gain insights into innovative drug development processes, biomarker identification, and the latest clinical trials, focusing on improving survival rates and minimizing side effects. This session aims to bridge the gap between basic science and clinical applications, promoting a multidisciplinary approach to tackling cancer with precision and optimizing therapeutic regimens for diverse patient populations.
Environmental and Occupational Toxicology focuses on understanding the harmful effects of environmental pollutants and workplace chemicals on human health. This multidisciplinary field examines exposure pathways, toxicokinetics, and the molecular mechanisms of toxicants. Researchers investigate biomarkers, epidemiological trends, and preventive strategies to mitigate risks. With an emphasis on sustainable practices, the field aims to promote safer environments and enhance public health policies. Innovations in monitoring, risk assessment, and regulatory frameworks are essential in minimizing adverse outcomes. Join us at the conference to explore cutting-edge research and collaborate on solutions for global environmental and occupational health challenges.
Pharmacological interventions play a critical role in the management of mental health disorders. Medications such as antidepressants, antipsychotics, and mood stabilizers are employed to alleviate symptoms, restore balance in neurotransmitter systems, and enhance patient outcomes. Recent advancements in pharmacotherapy focus on personalized treatment regimens, minimizing side effects, and improving efficacy. Research into novel compounds and their mechanisms of action offers promising avenues for treating complex psychiatric conditions. Continued exploration of pharmacological strategies is essential for enhancing the quality of care and supporting patients in achieving long-term stability and well-being.
Air and water pollution pose significant toxicological risks to human health and ecosystems. Exposure to hazardous pollutants, including particulate matter, heavy metals, and chemical contaminants, disrupts biological systems, leading to respiratory diseases, cardiovascular complications, and neurological disorders. Pollutants can bioaccumulate, impacting biodiversity and environmental sustainability. The effects are particularly pronounced in vulnerable populations, including children and those with pre-existing conditions. Understanding the mechanisms of toxicity, along with innovative mitigation strategies, is crucial for reducing the global burden of pollution-related diseases. Collaborative efforts across disciplines are essential to develop effective policies and technologies that promote cleaner air and water systems.
Antibiotic resistance poses a significant global health threat, driven by the overuse and misuse of antimicrobial agents. Drug-resistant pathogens, including bacteria, viruses, and fungi, have evolved mechanisms to evade standard treatments, complicating infection management. This escalating issue necessitates urgent action, including the development of novel therapeutics, alternative treatment strategies, and enhanced surveillance systems. Multidisciplinary collaboration among researchers, clinicians, and policymakers is essential to combat the growing prevalence of resistant infections. Addressing antibiotic resistance requires a comprehensive approach, prioritizing prevention, stewardship, and innovation to safeguard public health and preserve the efficacy of existing antibiotics.
Natural products and herbal medicine offer significant therapeutic potential, providing novel solutions for diverse medical conditions. Their pharmacological properties, including antioxidant, anti-inflammatory, and antimicrobial effects, are gaining widespread attention in modern healthcare. These bioactive compounds, derived from plants, fungi, and marine organisms, serve as the foundation for many traditional remedies and continue to inspire pharmaceutical research. The growing interest in sustainable, plant-based treatments highlights the importance of integrating herbal medicine into contemporary medicine. Research in this field explores mechanisms of action, efficacy, and safety, paving the way for future innovations in natural therapeutics and personalized care.
Nanotoxicology and nanomedicine represent transformative approaches in drug delivery, offering unprecedented precision in targeting diseased tissues. Understanding the interactions between nanomaterials and biological systems is crucial for optimizing therapeutic outcomes while minimizing toxicity. Through controlled release mechanisms and enhanced bioavailability, nanoparticles facilitate more effective treatments for a range of conditions, including cancer and neurological disorders. Rigorous investigation into the biocompatibility, pharmacokinetics, and safety profiles of these nanomaterials is essential for their clinical translation. This session will explore cutting-edge research, providing insights into the balance between efficacy and safety in nanomedicine applications. Join us for an in-depth discussion on this dynamic field.
Endocrine disruptors are chemicals that interfere with the endocrine system, potentially altering reproductive health and development. These compounds can mimic or block hormones, disrupting normal physiological functions. In reproductive toxicology, the focus is on understanding how these disruptors affect fertility, gestation, and offspring development. Exposure to endocrine-disrupting chemicals (EDCs) has been linked to various reproductive health issues, including reduced fertility, birth defects, and developmental disorders. Investigating EDCs' mechanisms of action is crucial for developing effective regulatory policies and strategies to mitigate their impact on human health. This session will explore the latest advancements in endocrine disruption and reproductive toxicology research.
Participant Options & Benefits
Euro Pharmacology 2025 offers a range of participant options and benefits designed to enhance your conference experience and maximize your professional development. Participants can choose from the following options:
1. Presenter Registration:
Opportunity to present your research findings through oral or poster presentations.
Feedback from peers and experts in the field.
Publication opportunities in conference proceedings or affiliated journals.
2. Delegate Registration:
Access to all scientific sessions, keynote lectures, and workshops.
Networking opportunities with fellow professionals and experts in the field.
Conference materials, including abstract books and program schedules.
3. Student Registration:
Special rates for students currently enrolled in academic programs.
Access to educational sessions and networking opportunities.
Opportunity to showcase research projects through poster presentations.
4. Industry Registration:
Exhibition space to showcase products, services, and innovations.
Networking opportunities with key opinion leaders and professionals.
Brand visibility among a targeted audience of healthcare professionals.
5. Virtual Attendance:
Access to live-streamed sessions and on-demand recordings.
Participation in interactive sessions and virtual networking events
.
.
Flexibility to attend sessions from anywhere in the world.
Benefits for Participants:
Stay updated on the latest advancements and research findings in nephrology and urology.
Expand your professional network and connect with peers and experts in the field.
Enhance your knowledge and skills through interactive workshops and educational sessions.
Explore career opportunities and collaborations in nephrology and urology.
Earn continuing education credits and enhance your professional credentials.
Join Us at Euro Pharmacology 2025 whether you are a researcher, clinician, student, or industry professional, Euro Pharmacology 2025 offers a valuable opportunity to learn, network, and collaborate with experts in the field. Register today and be a part of this exciting event in Paris, France !
Abstract Review Process
Abstract Review Process for the 21st Annual Congress on Pharmacology and Toxicology
Submission and Initial Review:
Submit your abstract through the conference submission portal.
The organizing committee will review all submitted abstracts for relevance to the conference, originality, and scientific quality.
Acceptance and Notification:
Once the review is completed, you will receive an Abstract Acceptance Letter if your submission is accepted.
Accepted abstracts will require the presenting author to register for the conference.
Registration Requirements:
A single registration permits only one person to attend the conference.
If you have co-authors who wish to attend the conference, they need to register and pay independently.
Co-authors will receive a 15% discount on the Non-Presenter’s (Listener’s) Registration Fee.
Certification:
Certificates will be issued to co-authors only upon their registration and payment for the conference.
Discount and Communication:
To avail of the co-author discount, make sure to communicate with the organizing committee prior to registration.
Important Information for Co-Authors:
Each co-author attending the conference must register and pay the registration fee independently.
Co-authors are eligible for a 15% discount on the Non-Presenter’s (Listener’s) Registration Fee.
Ensure prior communication with the organizing committee to facilitate the discount.
Certificates will be provided to registered co-authors.
For further information or assistance, please contact the organizing committee.
Visa Process
Visa Process for the 21st Annual Congress on Pharmacology and Toxicology
Planning to attend the 21st Annual Congress on Pharmacology and Toxicology November 20-21, 2025 Paris, France? Here's a comprehensive guide to help you navigate the visa process smoothly.
Step-by-Step Guide to the Visa Application Process
Step 1: Registration
The first step in your journey to the 6th International Conference on Kidney Failure & Renal Care is to complete your registration. Once your registration is confirmed, you will receive an official invitation letter. This letter is crucial as it will support your visa application, demonstrating the purpose of your visit to Dubai.
Step 2: Determine the Type of Visa
Most international delegates will require a short-stay Schengen visa for France. This visa permits stays of up to 90 days within a 180-day period for tourism, business, or attending conferences.
Step 3: Gather Required Documents
Prepare the necessary documentation for your visa application. Typical requirements include:
- A valid passport (with at least three months validity beyond your intended departure date)
- Completed visa application form
- Official invitation letter from the 21st Annual Congress on Pharmacology and Toxicology
- Travel itinerary (flight reservations)
- Proof of sufficient financial means (bank statements, proof of income)
- Travel insurance covering medical expenses and repatriation for the entire duration of your stay
Step 4: Schedule a Visa Appointment
Contact the French consulate or embassy in your country to schedule an appointment for your visa application submission. Be sure to book this appointment well in advance, as appointment slots can fill up quickly, especially during peak travel seasons.
Step 5: Attend the Visa Interview
On the day of your appointment, arrive at the consulate or embassy with all required documents. During the interview, you may be asked about the purpose of your visit, your plans during your stay, and your ties to your home country to ensure that you intend to return after the congress.
Step 6: Wait for Visa Approval
After your interview, the processing time for a Schengen visa typically ranges from 10 to 15 days. It is advisable to apply at least one month before your planned departure to allow sufficient time for processing.
Step 7: Collect Your Visa
Once your visa is approved, you will be notified to collect your passport with the visa sticker affixed. Double-check the visa details for accuracy and familiarize yourself with any specific entry requirements.
Additional Tips
- Early Preparation: Start your visa application process as early as possible to avoid any last-minute issues.
- Accurate Documentation: Ensure all documents are complete and accurate to prevent delays in processing.
-Travel Insurance: Make sure your travel insurance policy meets Schengen requirements, including coverage for medical emergencies and repatriation.
By following these steps, you can ensure a smooth and hassle-free visa application process. Register now and prepare to join us in Paris, France for an inspiring and informative gathering of minds at the 21st Annual Congress on Pharmacology and Toxicology!
We look forward to welcoming you to Paris, France!
Market Analysis
The size of the pharmaceutical market is expected to reach $ 2,151.1 billion by 2027. The pharmaceutical market was worth $ 5.32 billion in 2019 and will post a CAGR of 7% during the forecast period. The increasing attention to the healthcare sector in the context of the pandemic is expected to drive the growth of the market in the near future. The Pharmaceuticals Market report offers an in-depth analysis of the Pharmaceuticals industry and demand drivers, highlighting information on several aspects of the market.
The global market is segmented into drugs and vaccines. As an indication, the market is divided into oncology, diabetes, anti-viral, cardiovascular disorders, neurological disorders, anti-infective, respiratory disorders, and anti-hypertensive. In terms of region, the market is divided into North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Large companies in the global pharmaceutical market are increasingly focusing on research and development activities to create new and innovative products in order to stay ahead of the competition.
In recent years, major drug manufacturers have turned to external service providers for R&D and manufacturing services. Growing demand for personalized products, the need to improve productivity and efficiency throughout the value chain, and continued pressure from regulators on drug prices have forced pharmaceutical companies to rely on more on how to outsource drug development. Most large-scale drug makers opt for in-house production, as it allows companies to control the private information associated with new molecules. The expansion of in-house manufacturing facilities by key companies is also driving the growth of the segment.
give 25 sessions/tracks for 21st Annual Congress on Pharmacology and Toxicology represent to present health condition in world
Clinical Pharmacology and Therapeutics with just 100 words use high indexed words and avoid spam trigger words for conference website
To Collaborate Scientific Professionals around the World
Conference Date November 20-21, 2025
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Past Conference Report
Supported By
Journal of Clinical Toxicology
Journal of Forensic Toxicology & Pharmacology
Clinical Pharmacology & Biopharmaceutics
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by
